Australia markets close in 3 hours

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4600-0.1400 (-5.38%)
At close: 04:00PM EDT
2.4800 +0.02 (+0.81%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,114
1,775
7,411
4,112
30,482
Operating expenses
Research development
251,831
249,240
94,245
88,017
95,258
Selling general and administrative
91,615
53,752
37,248
27,203
29,315
Total operating expenses
343,446
302,993
131,493
115,220
124,573
Operating income or loss
-341,332
-301,218
-124,082
-111,109
-94,091
Interest expense
1,584
1,936
8,702
7,949
-
Total other income/expenses net
-12,800
-3,433
-33,418
-4,358
-1,628
Income before tax
-352,522
-303,224
-162,890
-120,809
-94,798
Income tax expense
-
0
0
-257.335
2,170
Income from continuing operations
-354,688
-303,659
-167,475
-120,552
-96,968
Net income
-354,688
-303,659
-166,411
-119,359
-96,968
Net income available to common shareholders
-354,688
-303,659
-166,411
-119,359
-96,968
Basic EPS
-
-1.45
-1.07
-1.21
-1.05
Diluted EPS
-
-1.45
-1.07
-1.21
-1.05
Basic average shares
-
208,830
155,127
98,718
92,540
Diluted average shares
-
208,830
155,127
98,718
92,540
EBITDA
-
-296,557
-149,560
-107,344
-89,094